IMCC (IM Cannabis) Other Stockholders Equity: $1.93 Mil (As of Mar. 2026)


IMCC IM Cannabis Corp IMCC
36 GF Score
Price $0.14
GF Value $1.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is IM Cannabis Other Stockholders Equity?

IM Cannabis IMCC +0.71% 36 Other Stockholders Equity is $1.93 Mil as of Mar. 2026. GuruFocus rates IMCC with a GF Score™ of 36/100 and a GF Value™ of $1.39 (Possible Value Trap). The stock has 5 warning signs investors should review.

IM Cannabis's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $1.93 Mil.

IM Cannabis's quarterly Other Stockholders Equity increased from Jun. 2025 ($-1.90 Mil) to Dec. 2025 ($1.92 Mil) and increased from Dec. 2025 ($1.92 Mil) to Mar. 2026 ($1.93 Mil).

IM Cannabis's annual Other Stockholders Equity declined from Dec. 2023 ($7.18 Mil) to Dec. 2024 ($0.31 Mil) but then increased from Dec. 2024 ($0.31 Mil) to Dec. 2025 ($1.92 Mil).

IM Cannabis Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for IM Cannabis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Other Stockholders Equity Chart

IM Cannabis Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.65 11.17 7.18 0.31 1.92

IM Cannabis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.32 -1.90 1.92 1.93
IMCC
36GF Score
IM Cannabis Corp IMCC
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IM Cannabis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $1.93 Mil mean?
IM Cannabis (IMCC) has a Other Stockholders Equity of $1.93 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on IM Cannabis and its competitors.
Is IM Cannabis' Other Stockholders Equity too high?
IM Cannabis' current Other Stockholders Equity is $1.93 Mil. Overall, IM Cannabis has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' Other Stockholders Equity compare to BSPK and NPHC?
IM Cannabis' Other Stockholders Equity of $1.93 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on IM Cannabis and its competitors. IM Cannabis's current Other Stockholders Equity is $1.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.39, compared to a current price of $0.14 — trading 89.8% below its estimated fair value. The current Other Stockholders Equity is $1.93 Mil. IM Cannabis' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For IM Cannabis (IMCC), the current Other Stockholders Equity is $1.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.14 is trading 89.8% below its estimated GF Value™ of $1.39. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Other Stockholders Equity: $1.93 Mil
  • GF Value™: $1.39 vs. price of $0.14 (89.8% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score

Get the complete analysis for IMCC

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$1.39
GF Value